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Abstract
Background: Peripartum hysterectomy can cause significant morbidity and mortality. Most studies of peripartum
hysterectomy are from high income countries. This cohort study examined risk factors for peripartum hysterectomy
using data from Africa, Asia, Europe and the Americas.
Methods: We used data from the World Maternal Antifibrinolytic (WOMAN) trial carried out in 193 hospitals in 21
countries. Peripartum hysterectomy was defined as hysterectomy within 6 weeks of delivery as a complication of
postpartum haemorrhage. Univariable and multivariable random effects logistic regression models were used to
analyse risk factors. A hierarchical conceptual framework guided our multivariable analysis.
Results: Five percent of women had a hysterectomy (1020/20,017). Haemorrhage from placenta praevia/accreta
carried a higher risk of hysterectomy (17%) than surgical trauma/tears (5%) and uterine atony (3%). The adjusted
odds ratio (AOR) for hysterectomy in women with placenta praevia/accreta was 3.2 (95% CI: 2.7–3.8), compared to
uterine atony. The risk of hysterectomy increased with maternal age. Caesarean section was associated with fourfold
higher odds of hysterectomy than vaginal delivery (AOR 4.3, 95% CI: 3.6–5.0). Mothers in Asia had a higher
hysterectomy incidence (7%) than mothers in Africa (5%) (AOR: 1.2, 95% CI: 0.9–1.7).
Conclusions: Placenta praevia/accreta is associated with a higher risk of peripartum hysterectomy. Other risk factors
for hysterectomy are advanced maternal age, caesarean section and giving birth in Asia.
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Conceptual framework
Background
Peripartum hysterectomy is performed at the time of de-
livery, or at any time from delivery to discharge from the
same hospitalisation. The main indication for peripar-
tum hysterectomy is severe uterine haemorrhage that
cannot be controlled by conservative measures [1]. Peri-
partum hysterectomy is a “near-miss” maternal event -
an intervention performed in life threatening obstetric
situations to prevent death [2]. It results in the loss of
fertility and is associated with significant maternal mor-
bidity and mortality [3].
Worldwide, the rate of peripartum hysterectomy varies
widely. In high income countries less than one in 1000
deliveries is complicated by peripartum hysterectomy
[4–10], whereas in Nigeria [11] and Pakistan [12] the in-
cidence is 4 and 11 per 1000 deliveries, respectively. The
rate of emergency peripartum hysterectomy has been in-
creasing over time [7–9, 13–15]. In USA, it increased by
12% between 1998 and 2003 [9] and by 15% between
1995 and 2007 [13].
The risk factors for peripartum hysterectomy are ad-
vanced maternal age, abnormal placentation, higher
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parity, and caesarean delivery in previous or current
pregnancy [1, 16]. An increased risk of hysterectomy as-
sociated with placental pathologies and caesarean sec-
tions has been reported in several studies [5–7, 9, 10, 15,
17].
Individual studies on peripartum hysterectomy have
small sample sizes, and the definition of peripartum hys-
terectomy varies across studies making comparisons dif-
ficult [16]. Systematic reviews often exclude studies
conducted in underdeveloped nations [16, 18], or have
an underrepresentation of women in poor countries [1].
In this study we used data from a large multinational
clinical trial, in which most women were from Africa
and Asia. The objective of this study was to i) determine
the association between placenta praevia/accreta and the
risk of emergency hysterectomy and ii) investigate the
association between demographic and delivery-related
risk factors and emergency hysterectomy.
Methods
Study design and data source
This is a cohort study using data from the World Mater-
nal Antifibrinolytic (WOMAN) trial, which was a large,
randomised, double blinded, placebo controlled trial con-
ducted in 193 hospitals in 21 countries [19]. Women diag-
nosed with postpartum haemorrhage (PPH) were
randomised to receive tranexamic acid or placebo. Base-
line data were recorded in an entry form prior to random-
isation and outcome data collected at death, discharge
from hospital or 42 days following randomisation, which-
ever occurred first [20]. All women with a completed out-
come form were included in our cohort study, irrespective
of the trial arm they were randomised to.
Our study outcome was defined as hysterectomy per-
formed before discharge or within 6 weeks of delivery.
The primary exposure of interest was placenta praevia/
accreta as cause of haemorrhage. Other risk factors eval-
uated in this study include, maternal age, geographic re-
gion, delivery in study hospital, administration of
prophylactic uterotonics, type of delivery, full delivery of
placenta, systolic blood pressure (SBP), estimated vol-
ume of blood loss, and clinical signs of haemodynamic
instability. Countries were categorised into three geo-
graphic regions as follows: Africa - Burkina Faso,
Cameroon, Cote d’Ivoire, Democratic Republic of
Congo, Egypt, Ethiopia, Ghana, Kenya, Nigeria, Sudan,
Tanzania, Uganda and Zambia; Asia - Bangladesh,
Nepal, Pakistan, Papua New Guinea; Europe and the
Americas - Albania, Colombia, Jamaica and United
Kingdom.
Statistical analyses
Stata 14 was used for all statistical analyses [21]. We
used frequencies and percentages to describe the
characteristics of the study population. For variables
with more than 1% missing data (uterotonics adminis-
tered prophylactically), we explored to check if missing-
ness was random. To account for clustering of subjects
at the hospital level, we fitted random effects logistic re-
gression models adjusting for hospital. We included age
as a forced variable, a priori, for all univariable analyses.
Drawing on prior knowledge, we hypothesized vari-
ables that might be confounders and those that might be
in the causal pathway between our primary exposure
and outcome [22]. We excluded full delivery of placenta
from multivariable models since any placental pathology
would affect its delivery. Variables reflecting haemo-
dynamic status such as blood pressure and blood loss
volume were identified as mediators, because cause of
haemorrhage can influence these variables and subse-
quently the need for hysterectomy. The hierarchical con-
ceptual framework shown in Fig. 1 guided our analysis.
A forward approach was used to build multivariable
models. Exposure variables in model 1 were cause of
PPH, age, geographic region, delivery in study hospital,
administration of prophylactic uterotonics and type of
delivery. Model 2 included variables in model 1 plus sys-
tolic blood pressure, estimated volume of blood loss and
clinical signs of haemodynamic instability. For each hier-
archy, the association between cause of haemorrhage
and hysterectomy was adjusted by adding variables one
at a time, based on the magnitude of effect in crude ana-
lysis. As each variable was added to the model, we
assessed for collinearity. After fitting a preliminary final
model, negative confounding was explored by including
variables that were initially excluded. A variable was a
negative confounder if it did not show an association at
univariable analysis, but became associated with the out-
come at multivariable analysis (p < 0.05). Once a full
model was identified, for each hierarchy, risk factors
were evaluated statistically using the likelihood ratio test.
Results
Table 1 shows characteristics of the 20,021 study partici-
pants. The mean maternal age was 28 years (standard
deviation: 6 years). Sixty four percent of mothers were
from Africa and 31% from Asia. The most common
cause of postpartum haemorrhage was uterine atony
(64%), followed by surgical trauma (18%) and placenta
praevia/accreta (9%). Most mothers (88%) gave birth at
study hospitals, whereas 12% gave birth in other settings
and were referred to study sites after PPH onset. Seventy
one percent of mothers delivered vaginally and 29% had
caesarean sections.
There were 484 women with missing data for utero-
tonic prophylaxis. They had a higher risk of hysterec-
tomy (odds ratio 1.5, 95% CI: 1.0–2.1, p = 0.04)
compared to women with data for uterotonic
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prophylaxis. Among the women with missing data for
uterotonic prophylaxis, 468 (97%) gave birth in a setting
other than the study sites. The remaining exposure vari-
ables had less than 1 % missing data. Four women had
missing outcome data.
The risk of peripartum hysterectomy within 6 weeks
of PPH diagnosis was 5% (1020/20,017). The risk of
hysterectomy for uterine atony, surgical trauma/tears
and placenta praevia/accreta was three, five and 17 %,
respectively (Table 2). The incidence of hysterectomy
was 1% in mothers under 20 years and 13% in
mothers who were 40 and above. The risk of hyster-
ectomy varied by geographic region: 7% in Asia and
5% in Africa. Women having caesarean sections had a
higher risk of hysterectomy (11%) than women who
delivered vaginally (3%). The age-adjusted odds ratio
for placenta praevia/accreta and hysterectomy was 4.9
(95% CI: 4.1–5.8) compared to uterine atony.
The timing of hysterectomy differed by cause of bleed-
ing. The median time between PPH diagnosis and hys-
terectomy was 0.6 h for placenta praevia/accreta,
compared to ≥1.3 h for uterine atony, surgical trauma/
tears and other/unknown causes of PPH. The median
time between PPH diagnosis and hysterectomy was
shorter in Asia (0.8 h) than in Africa (1.6 h). The time
from PPH to hysterectomy in Asia was 0.5 h for placenta
praevia/accreta, 0.9 h for surgical trauma/tears and 1.0 h
for uterine atony. The time from PPH to hysterectomy
in Africa was 1.3 h for placenta praevia/accreta, 1.9 h for
surgical trauma and 1.8 h for uterine atony.
Table 3 shows adjusted odds ratios (AOR) for the
association between exposure variables and hysterec-
tomy. Placenta praevia/accreta was associated with a
threefold higher risk of peripartum hysterectomy than
uterine atony (AOR 3.2, 95% CI: 2.7–3.8). The AORs
for hysterectomy and maternal age was 1.6 (95% CI:
0.9–2.9) in 20–29 years, 4.0 (95% CI: 2.2–7.1) in 30–
39 years and 7.6 (95% CI: 4.0–14.3) in ≥40 years
compared to < 20 years. Mothers in Asia had a 23%
higher risk of hysterectomy than mothers in Africa,
although the estimate was imprecise in model 1. After
adjusting for variables in model 2 the odds ratio for
hysterectomy in women giving birth in Asia was 2.2
(95% CI: 1.5–3.1) compared to women giving birth in
Africa. The odds of hysterectomy was fourfold higher
in women having caesarean sections than in women
delivering vaginally (AOR 4.3, 95% CI: 3.6–5.0). There
was strong evidence that the association between type
of delivery and hysterectomy varied by cause of
haemorrhage (p-value for interaction < 0.001). The ad-
justed odds ratio for caesarean section and hysterec-
tomy was 10.0 (95% CI: 6.2–16.0) in women with
placenta praevia/accreta, 3.4 (95% CI: 2.8–4.3) in
women with uterine atony and 3.7 (95% CI: 2.6–5.2)
in women with surgical trauma/tears. Place of delivery
was a negative confounder, that was not associated
with hysterectomy on univariable analysis but became
associated on multivariable analysis. Women who de-
livered somewhere other than study hospitals were
one and half times more likely to undergo hysterec-
tomy (AOR 1.6, 95% CI: 1.3–2.1).
In our cohort of 20,021 women, 483 (2%) died. Mor-
tality from postpartum haemorrhage was 3% (375/
12,718) in Africa, 2% in Asia (106/6173) and 0.2% (2/
1130) in Europe and the Americas. Out of 1020 mothers
who had hysterectomies, 163 died. The overall case fatal-
ity rate was 16 per 100 hysterectomies. Death rate
among hysterectomy cases was higher in Africa than in
Fig. 1 Hierarchical conceptual framework of risk factors for hysterectomy in women with postpartum haemorrhage
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Asia, and Europe and the Americas: 20 compared to 11
and 7 per 100 hysterectomies, respectively.
The following sensitivity analyses were carried out and
they did not change the results of the main analysis: i)
Women who died before having a hysterectomy were ex-
cluded from multivariable analysis, ii) Women with SBP
≤30 mmHg were excluded from final models, and iii)
Sensitivity analysis for missing data for uterotonic
prophylaxis was carried out by assessing odds ratios in
extreme situations, when all women with missing data
received uterotonic prophylaxis and vice versa.
Discussion
Our study shows that haemorrhage from placenta prae-
via/accreta increases the risk of peripartum hysterec-
tomy. Other risk factors for hysterectomy are advanced
maternal age, having a caesarean section and giving birth
in Asia.
Our results should be interpreted in light of the study
strengths and limitations. Data collection was complete
and there was minimal missing data. The prospective
collection of exposure data minimised recall and obser-
ver bias. The outcome, hysterectomy was an objective
ascertainable variable unlikely to be misclassified. Meas-
urement error may have occurred with age, SBP and vol-
ume of blood loss. In areas without legally enforced
birth registration (e.g. some African and Asian coun-
tries), it can be argued that some women did not know
their age reliably. Nonetheless, any misclassification was
likely to be non-differential with minimal effect on result
interpretation.
This study had a large sample size. Women were re-
cruited from Africa and Asia where the incidence of PPH
is high, thus increasing the study’s statistical power. Our
results are generalizable to women with postpartum
haemorrhage in low and middle income countries. How-
ever it is worth mentioning that the study sites were se-
lected based on their ability to conduct a trial and the
level of obstetric service available. Women, who deliver in
hospitals involved in a multinational clinical trial, or are
referred to them, may not be representative of all women
who have PPH. Especially in regards to Africa and Asia,
these women may be better off socioeconomically and
Table 1 Baseline characteristics of women with postpartum
haemorrhage (N = 20,021)
Variable Number Percent
Cause of haemorrhage
Uterine atony 12,761 63.7
Surgical trauma/tears 3681 18.4
Placenta praevia/accreta 1875 9.4
Other/Unknown 1700 8.5
Missing 4 0.02
Age (years)
< 20 1021 5.1
20–29 10,410 52.0
30–39 7902 39.5
≥40 681 3.4
Missing 7 0.03
Mean (SD) 28.3 (5.7)
Geographic Region
Africa 12,718 63.5
Asia 6173 30.8
Europe and Americas 1130 5.6
Delivery in study hospital
Yes 17,590 87.9
No 2428 12.1
Missing 3 0.01
Uterotonic prophylaxis given
Yes 19,268 96.2
No 269 1.3
Missing 484 2.4
Type of delivery
Vaginal 14,191 70.9
Caesarean 5825 29.1
Missing 5 0.02
Full delivery of placenta
Yes 18,067 90.2
No 1951 9.7
Missing 3 0.01
Systolic Blood Pressure (mmHg)
≤70 1532 7.7
71–90 5927 29.6
> 90 12,557 62.7
Missing 5 0.02
Mean (SD) 100.8 (22.7)
Estimated volume of blood loss (mL)
≤ 1000 10,403 52.0
1001–1500 5704 28.5
> 1500 3911 19.5
Table 1 Baseline characteristics of women with postpartum
haemorrhage (N = 20,021) (Continued)
Variable Number Percent
Missing 3 0.01
Mean (SD) 1226.4 (617.8)
Clinical signs of haemodynamic instability
No 8194 40.9
Yes 11,826 59.1
Missing 1 < 0.01
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medically, and our study may have excluded rural and
poor women in these regions.
For multivariable analysis, we used sequential model-
ling of groups of risk factors according to their occur-
rence. This prevented adjusting for potential causal
intermediates and allowed separation of confounding
and mediating factors. We also adjusted for clustering at
the hospital level. However, unmeasured confounding
may have resulted from lack of data on risk factors such
as parity and prior caesarean section. A further
Table 2 Univariable analysis of risk factors for hysterectomy in women with postpartum haemorrhage
Variable Total n(%) of women who had hysterectomy Age-adjusted odds ratio (95% CI)a P-value†
Cause of haemorrhage
Uterine atony 12,759 421 (3.3) 1 < 0.001
Surgical trauma/tears 3681 181 (4.9) 1.49 (1.24–1.80)
Placenta praevia/accreta 1874 326 (17.4) 4.87 (4.11–5.77)
Other/Unknown 1699 90 (5.3) 1.40 (1.10–1.80)
Age (years)
< 20 1021 12 (1.2) 1 < 0.001
20–29 10,408 306 (2.9) 2.15 (1.20–3.86) < 0.001ǂ
30–39 7900 615 (7.8) 5.98 (3.34–10.70)
≥40 681 87 (12.8) 11.73 (6.30–21.85)
Geographic region
Africa 12,714 570 (4.5) 1 < 0.001
Asia 6173 420 (6.8) 1.67 (1.20–2.34)
Europe and Americas 1130 30 (2.7) 0.53 (0.26–1.08)
Delivery in study hospital
Yes 17,586 868 (4.9) 1 0.77
No 2428 152 (6.3) 0.97 (0.80–1.18)
Uterotonic prophylaxis given
Yes 19,264 940 (4.9) 1 < 0.001
No 269 40(14.9) 2.65 (1.80–3.88)
Type of delivery
Vaginal 14,188 357 (2.5) 1 < 0.001
Caesarean 5824 661 (11.4) 4.50 (3.89–5.21)
Full delivery of placenta
Yes 18, 064 796 (4.4) 1 < 0.001
No 1950 223 (11.4) 2.24 (1.89–2.66)
Systolic blood pressure (mmHg)
≤70 1532 210 (13.7) 6.40 (5.25–7.81) < 0.001
71–90 5925 453 (7.7) 3.02 (2.59–3.53) < 0.001ǂ
> 90 12,555 357 (2.8) 1
Estimated volume of blood loss (mL)
≤ 1000 10,400 86 (0.8) 1 < 0.001
1001–1500 5703 238 (4.2) 5.35 (4.13–6.93) < 0.001ǂ
> 1500 3911 696 (17.8) 32.02 (24.97–41.05)
Clinical signs of haemodynamic instability
No 8194 128 (1.6) 1 < 0.001
Yes 11,822 891 (7.5) 7.35 (5.96–9.06)
aCI, confidence interval
†P-values obtained from likelihood ratio test
ǂLikelihood ratio test for linear trend
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limitation of our study was the reporting of placenta
praevia and accreta as one variable; it would have been
informative to investigate each separately.
Our finding, of an increased risk of hysterectomy with
abnormal placentation is consistent with other literature
[1, 5, 7, 15, 16, 23]. In placenta accreta, the placental tis-
sue invades the myometrium. After birth, it remains
attached firmly to the uterine wall causing severe blood
loss. The time to attempt conservative management is
limited in placenta accreta, and obstetricians may
proceed to hysterectomy directly. This is reflected by a
shorter time gap between PPH diagnosis and hysterec-
tomy in women with placenta praevia/accreta compared
to other causes of haemorrhage. This pattern persisted
Table 3 Adjusted odds ratios for risk factors of hysterectomy in women with postpartum haemorrhage
Variable Model 1a Model 2b
AOR (95% CI)c P-value† AOR (95% CI)c P-value†
Cause of haemorrhage
Uterine atony 1 < 0.001 1 < 0.001
Surgical trauma/tears 1.42 (1.16–1.73) 1.21 (0.98–1.50)
Placenta praevia/accreta 3.17 (2.66–3.79) 2.25 (1.85–2.74)
Other/Unknown 1.34 (1.03–1.74) 0.97 (0.73–1.28)
Age (years)
< 20 1 < 0.001 1 < 0.001
20–29 1.62 (0.90–2.93) 1.47 (0.80–2.72)
30–39 3.96 (2.20–7.14) 3.33 (1.82–6.12)
≥40 7.59 (4.03–14.29) 5.89 (3.04–11.38)
Geographic region
Africa 1 0.01 1 < 0.001
Asia 1.23 (0.91–1.66) 2.16 (1.52–3.08)
Europe and Americas 0.45 (0.23–0.89) 0.69 (0.32–1.47)
Delivery in study hospital
Yes 1 < 0.001 1 0.06
No 1.60 (1.25–2.07) 0.77 (0.59–1.01)
Uterotonic prophylaxis given
Yes 1 < 0.001 1 < 0.001
No 2.68 (1.77–4.06) 2.57 (1.62–4.09)
Type of delivery
Vaginal 1 < 0.001 1 < 0.001
Caesarean 4.26 (3.60–5.04) 2.32 (1.92–2.80)
Systolic blood pressure (mmHg)
≤70 2.26 (1.79–2.87) < 0.001
71–90 1.68 (1.40–2.01)
> 90 1
Estimated volume of blood loss (mL)
≤ 1000 1 < 0.001
1001–1500 2.89 (2.19–3.83)
> 1500 12.88 (9.78–16.95)
Clinical signs of haemodynamic instability
No 1 < 0.001
Yes 3.50 (2.74–4.47)
aModel 1: cause of haemorrhage, age, geographic region, delivery in study hospital, uterotonic prophylaxis given and type of delivery
bModel 2: model 1 plus systolic blood pressure, estimated volume of blood loss and clinical signs of haemodynamic instability
cAOR: Adjusted odds ratio; CI: Confidence interval
†P-values obtained from likelihood ratio test
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after exclusion of women who were referred to study
hospitals from elsewhere, to account for travel time.
Some obstetricians opt for a conservative mode of treat-
ment in abnormal placentation and leave the placenta in
situ; however, this can lead to sepsis and secondary
haemorrhage and ultimately hysterectomy [24]. Further-
more, haemostatic interventions in placenta praevia/
accreta are associated with adverse effects. Radiological
balloons, embolization and B-Lynch sutures can cause
thrombosis, ischemia and neurological complications
[24]. Risk factors for placenta accreta include previous
caesarean section, other previous uterine surgery and ad-
vanced maternal age [25]. Caesarean section results in
scarring of the uterus, which in later pregnancies predis-
poses to abnormal placentation [26]. The main indica-
tion for peripartum hysterectomy has shifted in recent
decades from uterine atony to placenta accreta, in con-
junction with a rise in caesarean delivery rates [27].
After adjusting for confounders, we found a higher risk
of hysterectomy in older mothers. A lower threshold for
hysterectomy in older women, who are likely to have more
children, may explain this finding. We also found that
having a caesarean section increases mothers’ risk of hys-
terectomy. One possible explanation for this observation
is a lower threshold for hysterectomy during caesarean
section, when the patient is already in the operating room
and the uterus is readily accessible [18, 28]. In contrast,
practitioners may be more likely to try other methods to
control haemorrhage in vaginal deliveries because the
uterus is not readily available for removal. Another ex-
planation is that mothers undergo prenatal scanning with
ultrasonography and magnetic resonance imaging [29].
Women with a prenatal diagnosis of placenta praevia/
accreta are selected for caesarean section and may inevit-
ably require a hysterectomy. In our cohort, the risk of hys-
terectomy associated with caesarean section varied by
cause of haemorrhage. We found evidence that women
with placenta praevia/accreta had a higher risk of hyster-
ectomy associated with caesarean section than women
with other causes of PPH.
Our results showed that mothers in Asia have a higher
risk of hysterectomy than mothers in Africa. Caesarean
section, which is a risk factor for hysterectomy, is carried
out more frequently in Asia than in Africa [30]. The low
rates of caesarean delivery in sub-Saharan Africa are pre-
sumably due to low levels of access to emergency surgi-
cal care, lack of skilled workers and poor infrastructure
[31]. In the WOMAN trial, 25% of the deliveries in
Africa were caesarean sections, compared to 37% in Asia
and 32% in Europe and Americas. However, after adjust-
ing for type of delivery and other potential confounders,
the risk of hysterectomy remained high in Asia com-
pared to other regions. This finding may be due to re-
gional differences in obstetric practices and management
of PPH. Although the risk of hysterectomy was higher in
Asia than in Africa, mortality was lower (3% in Africa
and 2% in Asia). Analysis of maternal mortality using
country specific data found higher number of maternal
deaths in Africa than in Asia [32]. It is possible that by
carrying out hysterectomies promptly more lives are
saved in Asia, and fewer mothers die from postpartum
haemorrhage.
Conclusions
Our study found a strong association between placenta
praevia/accreta and peripartum hysterectomy. Other sig-
nificant risk factors include advanced maternal age, cae-
sarean section and giving birth in Asia. Preventing
avoidable causes of placenta accreta such as unnecessary
caesarean sections is recommended. Further research is
warranted to understand how maternal demographics
and local culture affect decision making in emergency
obstetric situations.
Abbreviations
AOR: Adjusted odds ratio; CI: Confidence interval; PPH: Postpartum
haemorrhage; SBP: Systolic blood pressure; SD: Standard deviation;
WOMAN: World Maternal Antifibrinolytic
Acknowledgements
The WOMAN trial collaborators and all the women who took part.
Funding
Funding for the WOMAN trial was provided by London School of Hygiene &
Tropical Medicine, Pfizer, Department of Health (grant number HICF-T2–
0510-007), the Wellcome Trust (grant number WT094947), and The Bill &
Melinda Gates Foundation (grant number OPP1095618). The funders had no
role in study design, data collection, analysis or interpretation, or writing of
the manuscript.
Availability of data and materials
The datasets generated and analysed during the current study are not yet
publicly available due to ongoing analyses of this recently completed trial.
After publication of the planned primary and secondary analyses, the trial
data will be made available via our data-sharing portal, The Free Bank of
Injury and Emergency Research Data (freeBIRD) website at https://ctu-
app.lshtm.ac.uk/freebird/.
Authors’ contributions
SH and IR identified the research question. SH was responsible for the
statistical analysis plan and data analysis. SH and IR drafted the manuscript.
SH, IR, BF, RC, SA and HS-S contributed to the interpretation of the results,
critical revisions of the manuscript and approved the final version.
Ethics approval and consent to participate
This is a secondary analysis of the WOMAN trial data. The need for ethics
approval and consent was waived as per national guidelines. The relevant
ethics committees and regulatory agencies approved the consent
procedures at each trial site for the original study. We obtained informed
consent from women if their physical and mental capacity allowed. If a
woman could not give consent, we obtained proxy consent from a relative
or representative. If no proxy was available, then if local regulation allowed,
we deferred or waived the consent. In these cases, we told the woman
about the trial as soon as possible and obtained consent for use of the data
collected. The consent procedures are described in detail in the Woman trial
protocol.
Competing interests
The authors declare that they have no competing interests.
Huque et al. BMC Pregnancy and Childbirth  (2018) 18:186 Page 7 of 8
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1Clinical Trials Unit, London School of Hygiene and Tropical Medicine, Keppel
Street, London WC1E 7HT, UK. 2Department of Obstetrics and Gynaecology,
National Institute of Maternal and Child Health, College of Medicine,
University of Ibadan, Orita-Mefa, Ibadan, Nigeria. 3Department of Obstetrics
and Gynaecology, Rawalpindi Medical University, Rawalpindi, Pakistan. 4St
George’s University, Cranmer Terrace, London SW17 0RE, UK.
Received: 20 February 2018 Accepted: 15 May 2018
References
1. van den Akker T, Brobbel C, Dekkers OM, Bloemenkamp KW. Prevalence,
indications, risk indicators, and outcomes of emergency peripartum
hysterectomy worldwide: a systematic review and meta-analysis. Obstet
Gynecol. 2016;128(6):1281–94.
2. Pattinson RC, Hall M. Near misses: a useful adjunct to maternal death
enquiries. Br Med Bull. 2003;67:231–43.
3. Wright JD, Devine P, Shah M, Gaddipati S, Lewin SN, Simpson LL, et al.
Morbidity and mortality of peripartum hysterectomy. Obstet Gynecol. 2010;
115(6):1187–93.
4. Sakse A, Weber T, Nickelsen C, Secher NJ. Peripartum hysterectomy in
Denmark 1995-2004. Acta Obstet Gynecol Scand. 2007;86(12):1472–5.
5. Campbell SM, Corcoran P, Manning E, Greene RA. Peripartum hysterectomy
incidence, risk factors and clinical characteristics in Ireland. Eur J Obstet
Gynecol Reprod Biol. 2016;207:56–61.
6. Knight M, Kurinczuk JJ, Spark P, Brocklehurst P. Cesarean delivery and
peripartum hysterectomy. Obstet Gynecol 2008;111(1):97–105.
7. Sahin S, Guzin K, Eroglu M, Kayabasoglu F, Yasartekin MS. Emergency
peripartum hysterectomy: our 12-year experience. Arch Gynecol Obstet.
2014;289(5):953–8.
8. Wen SW, Huang L, Liston R, Heaman M, Baskett T, Rusen ID, et al. Severe
maternal morbidity in Canada, 1991-2001. CMAJ. 2005;173(7):759–64.
9. Whiteman MK, Kuklina E, Hillis SD, Jamieson DJ, Meikle SF, Posner SF, et al.
Incidence and determinants of peripartum hysterectomy. Obstet Gynecol.
2006;108(6):1486–92.
10. Awan N, Bennett MJ, Walters WA. Emergency peripartum hysterectomy: a
10-year review at the Royal Hospital for women, Sydney. Aust N Z J Obstet
Gynaecol. 2011;51(3):210–5.
11. Omole-Ohonsi A, Olayinka HT. Emergency peripartum hysterectomy in a
developing country. J Obstet Gynaecol Can. 2012;34(10):954–60.
12. Khan B, Khan B, Sultana R, Bashir R, Deeba FA. Ten year review of
emergency peripartum hysterectomy in a tertiary care hospital. J Ayub Med
Coll Abbottabad. 2012;24(1):14–7.
13. Bateman BT, Mhyre JM, Callaghan WM, Kuklina EV. Peripartum hysterectomy
in the United States: nationwide 14 year experience. Am J Obstet Gynecol.
2012;206(1):63.e1–8.
14. Yoong W, Massiah N, Oluwu A. Obstetric hysterectomy: changing trends
over 20 years in a multiethnic high risk population. Arch Gynecol Obstet.
2006;274(1):37–40.
15. Bodelon C, Bernabe-Ortiz A, Schiff MA, Reed SD. Factors associated with
peripartum hysterectomy. Obstet Gynecol. 2009;114(1):115–23.
16. Rossi AC, Lee RH, Chmait RH. Emergency postpartum hysterectomy for
uncontrolled postpartum bleeding: a systematic review. Obstet Gynecol.
2010;115(3):637–44.
17. Kwee A, Bots ML, Visser GH, Bruinse HW. Emergency peripartum
hysterectomy: a prospective study in the Netherlands. Eur J Obstet Gynecol
Reprod Biol. 2006;124(2):187–92.
18. de la Cruz CZ, Thompson EL, O'Rourke K, Nembhard WN. Cesarean section
and the risk of emergency peripartum hysterectomy in high-income
countries: a systematic review. Arch Gynecol Obstet. 2015;292(6):1201–15.
19. WOMAN Trial Collaborators. Effect of early tranexamic acid administration
on mortality, Hysterectomy, and other morbidities in women with post-
partum haemorrhage (WOMAN): an international, randomised, double-blind,
placebo-controlled trial. Lancet. 2017;389:2105–16.
20. Shakur H, Elbourne D, Gulmezoglu M, Alfirevic Z, Ronsmans C, Allen E, et al.
The WOMAN trial (world maternal Antifibrinolytic trial): tranexamic acid for
the treatment of postpartum haemorrhage: an international randomised,
double blind placebo controlled trial. Trials. 2010;11:40.
21. StataCorp. Stata Statistical Software: Release 14. College Station: StataCorp
LP; 2015.
22. Victora CG, Huttly SR, Fuchs SC, Olinto MT. The role of conceptual
frameworks in epidemiological analysis: a hierarchical approach. Int J
Epidemiol. 1997;26(1):224–7.
23. Machado LS. Emergency peripartum hysterectomy: incidence, indications,
risk factors and outcome. N Am J Med Sci. 2011;3(8):358–61.
24. Chantraine F, Langhoff-Roos J. Abnormally invasive placenta–AIP. Awareness
and pro-active management is necessary. Acta Obstet Gynecol Scand. 2013;
92(4):369–71.
25. Fitzpatrick KE, Sellers S, Spark P, Kurinczuk JJ, Brocklehurst P, Knight M.
Incidence and risk factors for placenta accreta/increta/percreta in the UK: a
national case-control study. PLoS One. 2012;7(12):e52893.
26. Miller DA, Chollet JA, Goodwin TM. Clinical risk factors for placenta previa-
placenta accreta. Am J Obstet Gynecol. 1997;177(1):210–4.
27. Flood KM, Said S, Geary M, Robson M, Fitzpatrick C, Malone FD. Changing
trends in peripartum hysterectomy over the last 4 decades. Am J Obstet
Gynecol. 2009;200(6):632.e1–6.
28. Kacmar J, Bhimani L, Boyd M, Shah-Hosseini R, Peipert J. Route of delivery as
a risk factor for emergent peripartum hysterectomy: a case-control study.
Obstet Gynecol. 2003;102(1):141–5.
29. Palacios-Jaraquemada JM. Diagnosis and management of placenta accreta.
Best Pract Res Clin Obstet Gynaecol. 2008;22(6):1133–48.
30. Cavallaro FL, Cresswell JA, Franca GV, Victora CG, Barros AJ, Ronsmans C.
Trends in caesarean delivery by country and wealth quintile: cross-sectional
surveys in southern Asia and sub-Saharan Africa. Bull World Health Organ.
2013;91(12):914–22d.
31. Pearson L, Shoo R. Availability and use of emergency obstetric services:
Kenya, Rwanda, southern Sudan, and Uganda. Int J Gynaecol Obstet. 2005;
88(2):208–15.
32. WHO, UNICEF, UNFPA, United Nations, World Bank Group. Trends in
maternal mortality: 1990 to 2015. Estimates by WHO, UNICEF, UNFPA, World
Bank Group and the United Nations Population Divisions. Geneva: World
Health Organization; 2015.
Huque et al. BMC Pregnancy and Childbirth  (2018) 18:186 Page 8 of 8
